332 related articles for article (PubMed ID: 9570480)
1. Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes.
Alper RH; Nelson DL
Eur J Pharmacol; 1998 Feb; 343(2-3):303-12. PubMed ID: 9570480
[TBL] [Abstract][Full Text] [Related]
2. The putative <> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.
Cosi C; Koek W
Eur J Pharmacol; 2000 Jul; 401(1):9-15. PubMed ID: 10915831
[TBL] [Abstract][Full Text] [Related]
3. Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors.
Jerning E; Rosqvist S; Mohell N
J Recept Signal Transduct Res; 2002; 22(1-4):483-95. PubMed ID: 12503636
[TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
Meller E; Li H; Carr KD; Hiller JM
J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
[TBL] [Abstract][Full Text] [Related]
5. Native rat hippocampal 5-HT1A receptors show constitutive activity.
Martel JC; Ormière AM; Leduc N; Assié MB; Cussac D; Newman-Tancredi A
Mol Pharmacol; 2007 Mar; 71(3):638-43. PubMed ID: 17167032
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
[TBL] [Abstract][Full Text] [Related]
7. In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.
Jordan S; Chen R; Koprivica V; Hamilton R; Whitehead RE; Tottori K; Kikuchi T
Eur J Pharmacol; 2005 Jul; 517(3):165-73. PubMed ID: 15985260
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
Odagaki Y; Toyoshima R
Eur J Pharmacol; 2005 Oct; 521(1-3):49-58. PubMed ID: 16182280
[TBL] [Abstract][Full Text] [Related]
9. Serotonin 5-HT(1B/1D) agonist-stimulated [(35)S]GTPgammaS binding in rat and guinea pig striatal membranes.
Mize AL; Alper RH
Brain Res; 1999 Jul; 836(1-2):229-36. PubMed ID: 10415426
[TBL] [Abstract][Full Text] [Related]
10. Autoradiographic studies of 5-HT1A-receptor-stimulated [35S]GTPgammaS-binding responses in the human and monkey brain.
Dupuis DS; Pauwels PJ; Radu D; Hall H
Eur J Neurosci; 1999 May; 11(5):1809-17. PubMed ID: 10215933
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates.
Alper RH; Nelson DL
Eur J Pharmacol; 2000 Feb; 390(1-2):67-73. PubMed ID: 10708708
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxytryptamine1A and 5-hydroxytryptamine1B receptors stimulate [35S]guanosine-5'-O-(3-thio)triphosphate binding to rodent brain sections as visualized by in vitro autoradiography.
Waeber C; Moskowitz MA
Mol Pharmacol; 1997 Oct; 52(4):623-31. PubMed ID: 9380025
[TBL] [Abstract][Full Text] [Related]
13. S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptors.
Newman-Tancredi A; Chaput C; Verrièle L; Millan MJ
Eur J Pharmacol; 1996 Jun; 307(1):107-11. PubMed ID: 8831111
[TBL] [Abstract][Full Text] [Related]
14. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
[TBL] [Abstract][Full Text] [Related]
15. Autoradiography of serotonin 5-HT1A receptor-activated G proteins in guinea pig brain sections by agonist-stimulated [35S]GTPgammaS binding.
Dupuis DS; Palmier C; Colpaert FC; Pauwels PJ
J Neurochem; 1998 Mar; 70(3):1258-68. PubMed ID: 9489749
[TBL] [Abstract][Full Text] [Related]
16. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
Dupuis DS; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
[TBL] [Abstract][Full Text] [Related]
17. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
[TBL] [Abstract][Full Text] [Related]
18. Stimulated [35S]GTP gamma S binding by 5-HT1A receptor agonists in recombinant cell lines. Modulation of apparent efficacy by G-protein activation state.
Pauwels PJ; Tardif S; Wurch T; Colpaert FC
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):551-61. PubMed ID: 9402034
[TBL] [Abstract][Full Text] [Related]
19. 5-HT1A receptor agonist properties of antipsychotics determined by [35S]GTPgammaS binding in rat hippocampal membranes.
Odagaki Y; Toyoshima R
Clin Exp Pharmacol Physiol; 2007; 34(5-6):462-6. PubMed ID: 17439416
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors.
McLoughlin DJ; Strange PG
J Neurochem; 2000 Jan; 74(1):347-57. PubMed ID: 10617139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
